¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå ¿¹Ãø(-2030³â) : ÄÄÆ÷³ÍÆ®(¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º), ±â´É(°¡»ó Äɾî, 꺿, RPM, °ü¸®ÀÚ, ȯÀÚ Âü¿©), ¿ëµµ(¿ø°Ý ½Å°æ Áø·á, ¿ø°Ý ICU, ¿ø°Ý ¹æ»ç¼± Áø´Ü), ÃÖÁ¾»ç¿ëÀÚº°(ÀÇ·á Á¦°øÀÚ, º¸ÇèÀÚ)
AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030
»óǰÄÚµå : 1782036
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 385 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,941,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,325,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,429,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,024,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå ±Ô¸ð´Â 2024-2030³â¿¡ CAGR 36.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°ÝÁø·á ºÐ¾ßÀÇ AI ½ÃÀåÀº Åë½Å ±â¼ú ¹ßÀü, À¯¸®ÇÑ Á¤ºÎ Áö¿ø ¹× ±ÔÁ¦ Á¤Ã¥, RPM ½Ã½ºÅÛ È®´ë µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ¸¸¼ºÁúȯ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϰí, ºñ¿ë È¿À²ÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó¿¬µµ 2024-2030³â
±âÁØ¿¬µµ 2023³â
¿¹Ãø ±â°£ 2024-2030³â
´ÜÀ§ ±Ý¾×(´Þ·¯)
ºÎ¹® ÄÄÆ÷³ÍÆ®¡¤±â´É¡¤¿ëµµ¡¤ÃÖÁ¾»ç¿ëÀÚ¡¤Áö¿ª
´ë»ó Áö¿ª ºÏ¹Ì¡¤À¯·´¡¤¾Æ½Ã¾ÆÅÂÆò¾ç¡¤¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ & ¾ÆÇÁ¸®Ä«

´ç´¢º´, ½ÉÀåÁúȯ µî ¸¸¼ºÁúȯ Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿ø°ÝÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¡»ó ºñ¼­, ¿¹Ãø ºÐ¼®, ÀÚµ¿ ±â·Ï°ú °°Àº AI ±â¼úÀº ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È¿°ú¿Í Á¦°ø °¡´É¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2025³â 3¿ù ¹Ì±¹ÀÇ Eli Lilly and Company´Â ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ¹× Ä¡·á¸¦ À§ÇØ LillyDirect¶ó´Â ¿ø°Ý Áø·á ¼­ºñ½º¸¦ ½ÃÀÛÇß½À´Ï´Ù. ¿ø°ÝÀÇ·á±â±â´Â Àü¹®ÀÇ ºÎÁ·, ȯÀÚ ´ë±â½Ã°£ µîÀÇ ¹®Á¦¸¦ ÇØ°áÇϰí ÀÇ·áÀÇ Áú°ú ȯÀÚÀÇ °í±Þ ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

AI in Telehealth &Telemedicine Market-IMG1

ÄÄÆ÷³ÍÆ®º°·Î´Â ¼ÒÇÁÆ®¿þ¾î ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±â¾÷Àº ÀÎÇÁ¶ó °³¹ß¿¡ ÇÊ¿äÇÑ ÀÚº»À» Àý°¨ÇÒ ¼ö ÀÖ´Ù´Â ÀÌÀ¯·Î ¿ø°ÝÀÇ·á ¼ÒÇÁÆ®¿þ¾î µµÀÔÀ» ÃßÁøÇØ ¿Ô½À´Ï´Ù. AI¿Í ¸Ó½Å·¯´×(ML)À» žÀçÇÑ °í±Þ ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀº ¿¹Ãø ºÐ¼®, °³ÀÎÈ­, ¸ÂÃãÇü Äɾî Àü·« µîÀÇ ±â´ÉÀ» °®Ãß°í ÀÖÀ¸¸ç, ±â¾÷ÀÌ ¿ø°ÝÀÇ·á ¼Ö·ç¼ÇÀ» º¸±ÞÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ ºÎ¹®ÀÌ 2023³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM), ÀΰøÁö´É(AI), Ŭ¶ó¿ìµå ½Ã½ºÅÛÀ» ÅëÇØ ÀÇ·á ¼­ºñ½ºÀÇ °³ÀÎÈ­ ¹× Àû½Ã Á¦°øÀÌ °¡´ÉÇØÁ® ¿ø°Ý Áø·á µµÀÔ°ú ¸¸¼ºÁúȯ °ü¸® Áõ°¡¿¡ ´ëÇÑ ´ëÀÀÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ÀÇ·á±â°üµéÀÌ ´ë±â½Ã°£ ´ÜÃà°ú °ü¸® ¾÷¹«ÀÇ ºÎ´ãÀ» ÁÙÀ̱â À§ÇØ ¿ø°ÝÀÇ·á Ç÷§ÆûÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ºü¸£°Ô ¹ßÀüÇÏ´Â ÀÇ·á ÀÎÇÁ¶ó¿Í ±â¼ú Çõ½ÅÀÇ ÇýÅÃÀ» ¹Þ¾Æ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ °í·É Àα¸ Áõ°¡¿¡ µû¸¥ ÀÇ·á ¼ö¿ä Áõ°¡, ¸¸¼ºÁúȯ ¹ßº´·ü Áõ°¡, µðÁöÅÐ Çコ Á¦Ç° ÀÌ¿ë È®´ë µîÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ Á¤Ã¥µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ °¢Á¾ ¿µÇâ¿äÀÎÀÇ ºÐ¼®, ±â¼ú¡¤Æ¯ÇãÀÇ µ¿Çâ, ¹ý±ÔÁ¦ ȯ°æ, »ç·Ê ¿¬±¸, ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦7Àå ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå : ±â´Éº°

Á¦8Àå ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå : ¿ëµµº°

Á¦9Àå ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·á¿ë AI ½ÃÀå : Áö¿ªº°

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global AI in telehealth & telemedicine market is projected to grow at a CAGR of 36.4% between 2024 and 2030. The AI in telehealth & telemedicine market is rapidly expanding due to various factors such as advancements in telecommunication technologies, favorable government support and regulatory policies, and the expansion of RPM systems. An increase in the geriatric population necessitates the continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsComponent, Function, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

An increasing focus on the diagnosis of chronic illnesses such as diabetes and heart disease has led to an increased need for telehealth devices. AI technologies such as virtual assistants, predictive analytics, and automated note-taking help improve the effectiveness and availability of telehealth services. For instance, in March 2025, Eli Lilly and Company (US) introduced LillyDirect remote consultations to diagnose and treat Alzheimer's. Telehealth devices solve problems such as a lack of specialists and patient wait times, improving healthcare and patient access to advanced medical solutions.

AI in Telehealth & Telemedicine Market - IMG1

The software segment is expected to have the fastest growth rate in the AI in telehealth market during the forecast period, by component.

By component, the software segment is expected to be the fastest growing market during the forecast period. Companies have promoted telehealth software due to the need for less capital for infrastructural development. Advanced software platforms enhanced with AI and ML have predictive analytics, personalization, and tailored care strategies, which also help companies promote telehealth solutions. Companies such as Cisco Systems, Inc. (US) offer Cisco HealthPresence 2.5 software solutions. Additionally, in February 2025, Teladoc Health Inc. (US) acquired Catapult Health (US), a provider of virtual preventive care solutions, for USD 65 million; this acquisition supports Teladoc Health Inc. in strengthening its market position.

The healthcare providers segment accounted for the largest market share in 2023.

On the basis of end users, the healthcare providers segment accounted for the largest market share in 2023. RPM, AI, and cloud systems allow for the personalization and timely delivery of healthcare services, which helps manage the increasing adoption of remote consultations and chronic disease management. Many healthcare facilities have adopted the telehealth platform to reduce waiting periods and can handle large patient pools with less administrative workflow. For instance, Mercy Health (US) offers Mercy Virtual Care Services, serving over 600,000 patients across seven US states with more than 300 clinicians, delivering care through advanced technologies such as two-way video, online-enabled instruments, and real-time vital sign monitoring. The program enhances patient access and outcomes while reducing healthcare costs by enabling earlier interventions and continuous remote monitoring for those with chronic or complex conditions.

The Asia Pacific is estimated to register the fastest CAGR during the forecast period.

The AI in telemedicine market is geographically segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is projected to register the fastest CAGR during the forecast period as it benefits from the fast-developing healthcare infrastructure and technological advancements. In addition, the rising use of digital healthcare products, growing healthcare needs resulting from large geriatric populations, and an increasing incidence of chronic diseases drive regional growth. Government initiatives also promote market growth. In February 2024, South Korea's health ministry announced it would fully allow telemedicine services at all hospitals and clinics. In addition, India offers universal health coverage through the national telemedicine service (eSanjeevani), which covers 130 specialties. The platform has created 17,084 telemedicine hubs and serviced 364,497,645 patients to date. Government initiatives promoting telemedicine and improvements in digital health infrastructure also contributed to market growth.

Breakdown of supply-side primary interviews by company type, designation, and region:

List of Companies Profiled in the Report:

Research Coverage:

This research report categorizes the AI in telehealth & telemedicine market by component [hardware, software {(by modality: EHR-centric, Non-EHR-centric), (by integration type: integrated software, standalone software), (by deployment: on-premise deployment, cloud-based deployment)}, and services], by function [virtual care consultations, chatbots & virtual assistants, remote patient monitoring, virtual nursing care platform, clinical documentation, administrative workflows, analytics & reporting, patient engagement, and other functions[, by application [primary care, speciality care {teleradiology, telecardiology, teleneurology, diabetes, respiratory disorders, hypertension, teledermatology, telepsychiatry, other specialty care applications}, teleICU, and other applications], by end user [healthcare providers {hospitals; ambulatory surgery centers, ambulatory care centers, and other outpatient settings; long-term care & assisted living facilities; home healthcare; and other healthcare providers}, healthcare payers, patients, pharmaceutical & biotechnology companies, medtech companies, and other end users], and region. The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in telehealth & telemedicine market. A thorough analysis of the key industry players has provided insights into their business overview, offerings, and key strategies, such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the AI in telehealth & telemedicine market. This report covers the competitive analysis of upcoming startups in the AI in telehealth & telemedicine market ecosystem.

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall AI in telehealth and telemedicine market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

7 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

8 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

9 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER

10 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILE

13 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â